Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020554 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sara Torresan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico, 33081 Aviano, …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity, Molecular Targeted Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente).
Abstract (Originalsprache)
The treatment of Non Small Cell Lung Cancer (NSCLC) has been revolutionised by the introduction of targeted therapies. With the improvement of response and frequently of overall survival, however, a whole new set of adverse events emerged. In fact, due to the peculiar mechanism of action of each one of the tyrosine kinase inhibitors and other targeted therapies, every drug has its own specific safety profile. In addition, this safety profile could not fully emerge from clinical trials data, as patients in clinical practice usually have more comorbidities and frailties. Cardiotoxicity is a well-known and established adverse event of anti-cancer therapies. However, only recently it has become a central topic for targeted therapies in NSCLC, due to the unknown real range and frequency. Management of this toxicity begins with prevention, and must balance the need of continuing an effective anticancer treatment versus low risk of even fatal events and the preservation of long-term quality of life. The aim of this review is to summarise the current knowledge focusing on currently used targeted therapies in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico, 33081 Aviano, Italy.
- Department of Medicine (DME), University of Udine, 33100 Udine, Italy.
ORCID-Profile: Sara Torresan, Martina Bortolot, Elisa Bertoli, Brigida Stanzione, Alessandro Del Conte, Alessandra Bearz
Förderung
- Italian Ministry of Health (Ricerca Corrente)
Zitieren
APA
Torresan, S., Bortolot, M., De Carlo, E., Bertoli, E., Stanzione, B., Del Conte, A., Spina, M., & Bearz, A. (2025). Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020554
Vancouver
Torresan S, Bortolot M, De Carlo E, Bertoli E, Stanzione B, Del Conte A, et al. Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020554
BibTeX
@article{Torresan2025,
author = {Torresan, Sara and Bortolot, Martina and De Carlo, Elisa and Bertoli, Elisa and Stanzione, Brigida and Del Conte, Alessandro and Spina, Michele and Bearz, Alessandra},
title = {Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020554}
}
EUVIMED